Dr Eslam Shosha from McMaster University clarifies how to identify area postrema syndrome (APS) manifested by intractable nausea, vomiting, and hiccups, presents diagnostic criteria and a severity scale, and outlines the management strategy.
Dr Brittany B. Dennis, Dr Catherine Anne Lovatt, and Dr Elahn Pogue from McMaster University review current evidence for opioid substitution therapies and discuss risk mitigation and treatment selection for opioid use disorder (OUD).
Dr Nazanin Aghel from McMaster University outlines early and late cardiovascular events in patients after stem cell transplant.
Dr Sean Wharton from McMaster University describes bias and prejudice and their effects on medical care.
Dr Marie Pigeyre from McMaster University shares her knowledge on how to identify subtypes of type 2 DM and move towards personalized patient care.
Dr Andrew Perrella, Dr Sanjay Sonney, and Dr Duna Basudan from McMaster University summarize significant changes introduced in Surviving Sepsis Campaign 2021 guidelines.
Dr Kaveh G. Shojania from University of Toronto joins Dr Seychelle Yohanna to discuss the marginal effects of most efforts and biomedical research on health-care quality improvement.
Dr Aiman Alak from McMaster University joins Dr Khalid Azzam to review the role of optimal medical therapy in patients with heart failure with reduced ejection fraction (HFrEF).
Dr Rick Ikesaka from McMaster University explains the presentation and pathogenesis as well as strategies for the diagnosis, management, and prevention of UEDVT and catheter-related DVT.
Dr Shervin Zandi from McMaster University presents a comprehensive review of the expanding use of SGLT-2 inhibitors in the treatment of diabetes, heart failure, and chronic kidney disease.
English
Polski
Español
українська